Advertisement

Biden tests positive for COVID-19 for second straight day amid ‘rebound’ case

Click to play video: 'U.S. President Joe Biden tests positive for COVID-19, White House and First Lady assure he’s ‘doing good’'
U.S. President Joe Biden tests positive for COVID-19, White House and First Lady assure he’s ‘doing good’
WATCH: U.S. President Joe Biden tests positive for COVID-19, White House and First Lady assure he’s 'doing good' – Jul 21, 2022

President Joe Biden tested positive for COVID-19 for the second straight day, in what appears to be in a rare case of “rebound” following treatment with an anti-viral drug.

In a letter noting the positive test, Dr. Kevin O’Connor, the White House physician, said Sunday that the president “continues to feel well” and will keep on working from the executive residence while he isolates.

Biden tested positive on Saturday, requiring him to cancel travel and in-person events as he isolates for at least five days in accordance with Centers for Disease Control and Prevention guidelines.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

After initially testing positive on July 21, Biden, 79, was treated with the anti-viral drug Paxlovid. He tested negative for the virus on this past Tuesday and Wednesday, clearing him to leave isolation while wearing a mask indoors.

Story continues below advertisement

Research suggests that a minority of those prescribed Paxlovid to experience a rebound case of the virus. The fact that a rebound rather than a reinfection possibly occurred is a positive sign for Biden’s health once he’s clear of the disease.

“The fact that the president has cleared his illness and doesn’t have symptoms is a good sign and makes it less likely he will develop long COVID,” said Dr. Albert Ho, an infectious disease specialist at Yale University’s school of public health.

Sponsored content

AdChoices